Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 3Other hematologic neoplasm 2Myeloid 2Lymphoid 2Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Myelodysplastic Syndromes 160Leukemia, Myeloid, Acute 123Leukemia, Myelomonocytic, Chronic 65Leukemia 35Myeloproliferative Disorders 23Primary Myelofibrosis 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Anemia, Refractory, with Excess of Blasts 11Hematologic Neoplasms 10Myelodysplastic-Myeloproliferative Diseases 9Recurrence 8Multiple Myeloma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Neoplasms 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Lymphoma 5Polycythemia Vera 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Erythroblastic, Acute 4Hematologic Diseases 4Anemia, Refractory 4Thrombocythemia, Essential 3Prostatic Neoplasms 3Neoplasm, Residual 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3

Interventions

venetoclax 2ruxolitinib 2fludarabine phosphate 2Sirolimus 2Leucovorin 2Immunoglobulin G 2Doxorubicin 2Disulfides 2Cyclophosphamide 2Bortezomib 2Bevacizumab 2Azacitidine 2vactosertib 1trametinib 1temsirolimus 1sargramostim 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1olaparib 1neratinib 1lorlatinib 1lenvatinib 1idelalisib 1hydrocortisone sodium phosphate 1fludarabine 1enzalutamide 1entrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Azacitidine × Myeloid × Clear all
NCT05292664 2026-03-12

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Dana-Farber Cancer Institute

Phase 1 Recruiting
30 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasm Metastasis, Recurrence, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00384956 2016-12-12

A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

Washington University School of Medicine

Phase 2 Completed
25 enrolled 13 charts
Myeloid

Myelodysplastic Syndromes, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡